Samla, Sitti .

HRN: 28-92-44  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/15/2026
06/21/2026
ORAL
3ml
TID
Infectious Diarrhea
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: